🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05982808
Starting soon Not applicable

CLIF Correction VS. Conventional Correction Strategy for ASD

NCT05982808 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2024-07-01
Last updated
2023-08-09

Condition(s) studied

Spinal Deformity

Investigational drug(s) / intervention(s)

CLIF correctionconventional correction strategy

CLIF correction: CLIF correction was a novel surgical techqiue of correction of spinal deformtiy with minimal invasive approach

conventional correction strategy: conventional correction was the classic surgical techqiue of correction of spinal deformtiy with open posterior approach

Study summary

The present study intends to: 1)establish a multi-center large-sample randomized controlled trial to explore the technical advantages and surgical indications of the novel surgical technique of CLIF correction for ASD compared with the conventional correction strategy; 2)analyze the postoperative clinical and imaging results, and to explore the related complications and preventive measures; 3) establish 2-year follow-up to further quantify the clinical and radiographical outcomes of CLIF correction.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * adult spinal deformtiy; * 40yrs≤age≤80yrs; * Lenke-Silva classification II-V grade; * ineffective with conservative treatment; Exclusion Criteria: * severe osteoprosis with T value \<-2.5; * with preliminary spinal surgery; * ASA score≥III grade; * more than II degree spondylisthesis; * with mental disease;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Second Affiliated Hospital, School of Medicine, Zejiang University Hangzhou Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05982808 on ClinicalTrials.gov ↗ ← All trials in China